### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 15-20629

United States of America, State of California, State of Delaware, District of Columbia, State of Florida, State of Georgia, State of Hawaii, State of Illinois, State of Indiana, State of Louisiana, Commonwe alth of Massachusetts, State of Michigan, State of Mo ntana, State of Nevada, State of New Hampshire, State of New Jersey, Stat e of New Mexico, State of New York, State of Oklahoma, State of Rhode Island, Stat e of Tennessee, State of Texas, Commonwealth of Virginia, ex rel, SUSAN RUSCHER, qui tam relator,
Plaintiff - Appellant

v. OMNICARE, INCORPORATED; ACCU-M ED SERVICES, L.L.C.; ACCUMED SERVICES OF WASHINGTON, L.L.C.; ACCU-MED, INCORPORATED; OMNICARE PHARM ACY OF TEXAS 2, L.P.; OMNICARE PHARMACY OF FLORIDA, L.P.; ARLINGTON ACQUISITION I, INCORPORATED; ASCO HE ALTHCARE, L.L.C.; BADGER ACQUISITION OF TAMPA, L.L.C., do ing business as Bay Pharmacy; DR PHARMACARE, doing business as Omnica re of Louisville, Kentucky, doing business as Omnicare of Lexington, Kentucky; NCS HEALTHCARE OF MICHIGAN, INCORPORATED; NCS HEALTHCARE OF MINNESOTA, INCORPORATED; NCS HE ALTHCARE OF MISSOUR I, INCORPORATED; NCS HEALTHCARE OF NEW HAMP SHIRE, INCORPORATED; NCS HEALTHCARE OF NORTH CAROLINA, INCORPORATED,
Defendants - Appellees

Appeals from the United States District Court for the Southern District of Texas USDC No. 4:08-CV-3396 United States Court of Appeals Fifth Circuit 

### FILED October 28, 2016

Lyle W. Cayce Clerk Case: 15-20629 Document: 00513738048 Page: 1 Date Filed: 10/28/2016No. 15-20629

2 Before JOLLY, HAYNES, and GRAVES, Circuit Judges. PER CURIAM:* Susan Ruscher (“Relator”) appeals th e district court’s grant of summary judgment to Omnicare, Inc., on her False Claims Act (“FCA”) claims and analogous state law claims (collectively, “FCA claims”) and her Reverse False Claims Act (“Reverse FCA”) claim, and de nial of four discovery motions. For the reasons explained below, we AFFIRM. I. Background Omnicare is the nation’s largest prov ider of pharmacy services to longterm care facilities. It specializes in servicing geriatric patients living in nursing homes, referred to formally as skilled nursing facilities (“SNFs”), among other long-term care institution s. SNFs provide around-the-clock medical, nursing, and therapy services to residents, who usually have their pharmacy and drug costs reim bursed by Medicare Part A (“Part A”), Medicare Part D (“Part D”), or Medicaid. Part A benefits last for 100 days. To collect drug costs covered by Part A, Omnicare bills the SNFs. SNFs are compensated for Part A costs under a prospective system, whereby SNFs are pa id a per diem amount for each Part A resident to cover the co sts associated with caring fo r the resident, including pharmacy services. The per diem amou nt is based on the historical costs reported by all SNFs, and th is amount may or may not cover all of the patient’s expenses. To track allowable costs an d determine per diem amounts, SNFs are required to submit annual cost repo rts identifying the costs incurred for a given reporting period, incl uding costs that have yet to be paid. SNFs have one year following the end of the cost re porting period in which liability is

* Pursuant to 5 TH C IR . R. 47.5, the court has determined that this opinion should not be published and is not precedent except und er the limited circumstances set forth in 5 TH C IR . R. 47.5.4. Case: 15-20629 Document: 00513738048 Page: 2 Date Filed: 10/28/2016No. 15-20629

3 incurred to pay providers, such as Omnica re. If providers ar e not paid within one year and the payment period is no t extended under an exception, then SNFs must amend their cost reports through a “wor ksheet A-8 adjustment.” Once Part A benefits are exhausted, Part D and Medicaid benefits begin covering the drug costs incurred by cove red patients. Omnicare grew rapidly in the early 20 00s by acquiring a series of longterm care pharmacies. From 2002 to 20 05, Omnicare nearly doubled in size. Many of the new pharmacies , however, used disparat e billing systems, some of which failed to closely track and record payments to invoices. The SNFs involved in this lawsuit be gan actively auditing their Om nicare bills to identify erroneous charges, and these disputes sometimes took year s to resolve. Relator worked in Omni care’s collections depa rtment from July 2005 until August 2008, collecting past-due accounts receivables from SNFs. According to the parties, Omnicare and SNFs routinel y entered into preferred provider agreements, which designatedOmnicare as the SNFs’ preferred provider of pharmacy services and se t forth, among other things, pricing, payment terms, and billin g mechanisms. Relator became suspicious of Omnicare’s contract negotiations with clients owing past-due accounts receivables and expressed her concerns about potent ial Medicare fraud to superiors. She claims that her “resistanc e” to Omnicare’s co ntract negotiations eventually led to he r termination. Relator filed a qui tam action on behalf of the United States and twentytwo states against Omnica re and its affiliates, 1 alleging that Omnicare violated the FCA and twenty-two analogous state statutes by purportedly making, and causing SNFs to make, false clai ms for Medicare and Medicaid

1 Relator also included the SNFs as defe ndants in her original complaint but later dismissed them from the lawsuit. Case: 15-20629 Document: 00513738048 Page: 3 Date Filed: 10/28/2016No. 15-20629

4 reimbursements that allegedl y resulted from kickbacks in violation of the AntiKickback Statute (“AKS”). 2 Relator also brought a claim under the Reverse FCA, alleging that Omnicare violated an obligation to disclose a “reportable event” of Medicare fraud to the Offi ce of the Inspector General for the Department of Health and Human Serv ices (“OIG-HHS”) pu rsuant to a 2006 Corporate Integrity Agreement (“CIA”). 3 The district court limited the relevant time period fo r the FCA claims to thos e arising out of alleged kickbacks paid betw een January 1, 2005, and Dece mber 31, 2008. The United States and the twenty-two state gove rnments declined to intervene. The district court granted summar y judgment to Omnicare and dismissed all of Relator’s claims . Relator timely appealed. II. Standard of Review This court reviews “an order granting summary judgment de novo , applying the same standard as the district court.” Cooley v. Hous. Auth. of City of Slidell , 747 F.3d 295, 297 (5th Cir. 2014). Summary judgment is appropriate when “there is no genuine dispute as to any materialfact and the movant is entitled to judgment as a matter of law.” F ED

. R. C IV

. P. 56(a). A disputed fact is material if it has the potential to “affect the outcome of the suit under the governing law.” See Anderson v. Liberty Lobby, Inc. , 477 U.S. 242, 248 (1986). A district court’s discovery decisions are reviewed for an abuse of discretion. Moore v. Willis Indep. Sch. Dist. , 233 F.3d 871, 876 (5th Cir. 2000).

2 “The AKS provides no private right of a ction; therefore, a private plaintiff may not sue a health care provider under the AKS alone.” United States ex rel. Nunally v. W. Calcasieu Cameron Hosp. , 519 F. App’x 890, 893 n.5 (5th Cir. 2013) (citing 42 U.S.C. § 1320a– 7b(b)(1–2)); see also Ameritox, Ltd. v. Millennium Labs., Inc. , 803 F.3d 518, 522 (11th Cir. 2015) (noting that the AKS does not pr ovide a private right of action).

3 Relator also alleged a “False Records or Statements” claim and a “Conspiracy” claim under the FCA, but does not challenge the dismissal of those claims on appeal. Case: 15-20629 Document: 00513738048 Page: 4 Date Filed: 10/28/2016No. 15-20629

5 III. Discussion A. Discovery Motions Relator claims that she was depriv ed of the necessa ry discovery to support her claims; she alle ges that the district cour t abused its discretion when it denied relief on four separate di scovery motions: (1) a motion to compel Omnicare to produce all documents rega rding potential CIA violations; (2) a motion to “reopen the 30 (b)(6) deposition” due to too many objections from Omnicare in the original deposition; (3) a motion for leave to depose Omnicare’s former Chief Compliance Officer, who headed an in ternal committee responsible for CIA compliance; and (4) a motion seeking in camerareview of Omnicare’s privilege log because a tran script from a prior Omnicare case indicated Omnicare may have improperly asserted privilege in the present case (“Privilege Log Motion”). A district court’s discovery decisions ar e reviewed for abuse of discretion, and this court “will affirm such decision s unless they are arbitrary or clearly unreasonable.” Moore , 233 F.3d at 876. We have held that there was “nothing arbitrary or unreasonable” about denying a discover y motion for additional discovery when the lawsui t was pending for fourteen months before summary judgment, and the plaintiffs made a co nclusory argument that “they should have been allowed to ‘fullyexplore the Defendants’ cond uct . . . by taking their depositions,’ but d[id] not state what releva nt evidence they expected to uncover with additi onal discovery.” Id. ; see also United States ex rel. TaylorVick v. Smith , 513 F.3d 228, 233 (5th Cir. 2008) (similar). Relator argues that the district cour t’s denial of her discovery motions seeking evidence “central to her claims” constitutes re versible error. But she fails to “state what relevant evidence [s he] expected to unco ver with additional discovery.” See Moore , 233 F.3d at 876. Instead, her arguments as to the first three motions amount to co nclusory assertions that she “should have been Case: 15-20629 Document: 00513738048 Page: 5 Date Filed: 10/28/2016No. 15-20629

6 allowed to ‘fully explore [Omnicare’s] conduct.’” See id. Relator also failed to show that the district court abused its discretion in reject ing her claims of Omnicare’s non-compliance with discover y obligations. She instead offered evidence demonstrating, at most, a difference of opinion with the district court. Relator’s case was pend ing for more than seve n years before summary judgment; absent evidence showing wh at she expected to uncover with additional discovery, it was neither ar bitrary nor unreasonable for the district court to deny Relator’ s discovery motions. See id

. As to the Privilege Log Motion, th e district court declined to order in

camerareview based on conduct in anothe r Omnicare case because there was not enough information abou t the other case to infer misconduct in the present case. The district court’s order also reve als that “Relator id entified only seven individual documents that she believed may have been improperly withheld as privileged,” and Omnicare promptly determined that two of the seven documents were not privileged and ga ve those documen ts to Relator. Omnicare explained the basis of privile ge for the remaini ng five documents, “and Relator [did] not challenged thos e explanations.” The district court refused to infer improperconduct from the two wr ongly withheld emails because “even a careful privilege review could misclassify some documents.” The record does not reflect arbitrary or clearly unreasonable decision making. Accordingly, we hold that the district court did not abuse its discretion in denying these motions. We thus turn to the merits of th e summary judgment rulings. B. FCA Claims The FCA imposes civil liability and treble damages on any person who “knowingly presents, or causes to be pr esented, a false or fraudulent claim for payment or approval” to the United States government. 31 U.S.C. § 3729(a)(1)(A); see also United States ex rel. St eury v. Cardinal Health, Inc. , Case: 15-20629 Document: 00513738048 Page: 6 Date Filed: 10/28/2016No. 15-20629

7 625 F.3d 262, 267 (5th Cir. 2010). We have required plaintiffs to prove four elements to prevail on an FCA claim: “( 1) . . . there was a false statement or fraudulent course of conduct; (2) ma de or carried out with the requisite scienter; (3) that was material; and (4) that caused the gove rnment to pay out money or to forfeit mo neys due (i.e., that involved a claim).” United States ex rel. Longhi v. United States , 575 F.3d 458, 467 (5th Ci r. 2009) (quotation marks omitted). FCA claims can be either legally false or factually false. E.g. , United States v. Sci. Applications Int’l Corp. , 626 F.3d 1257, 1266 (D.C. Cir. 2010) (recognizing factually false claims as “th e paradigmatic case” and legally false claims as the “certification theory”). A claim is factually false when the information provided to the government for reimbu rsement is inaccurate. See,

e.g. , United States ex rel. Conner v. Salina Reg’l Health Ctr., Inc. , 543 F.3d 1211, 1217 (10th Cir. 2008). A claim is legally false when “a claimant . . . falsely certifies compliance with [a] statute orregulation

. ” See United States ex rel. Thompson v. Columbia /HCA Healthcare Corp. , 125 F.3d 899, 902 (5th Cir. 1997). Here, Relator primarily argues th at Omnicare made legally false Medicare and Medicaid claims. She co ntends that Omnicare knowingly made, or caused SNFs to make, false certifications of co mpliance with the AKS when submitting claims for reimbursement. For the alleged Part A claims, however, Relator also contends that Omnicare caused the SNFs to submit factually false claims. In support of this contenti on, she points to ev idence purportedly showing that the SNFs failed to accura tely report drug costs on Part A cost reports. As to her claim that Omnicare falsel y certified complianc e with the AKS, Relator bears the burden at the summary judgment sta ge to create a genuine issue of material fact about whet her Omnicare violated the AKS. See Malacara Case: 15-20629 Document: 00513738048 Page: 7 Date Filed: 10/28/2016No. 15-20629

8 v. Garber , 353 F.3d 393, 404 (5th Cir. 2003) (“To survive summary judgment, the nonmovant must submit oridentify evidence in the record to show the existence of a genuine issue of material fact as to each element of the cause of action.”). To this end, Relator primar ily contends that Om nicare paid unlawful kickbacks to SNFs by both not collect ing Part A debt and offering prompt payment discounts (“PPDs”) “to induce the SNFs to re fer patients to Omnicare who were covered under Part D and Medicaid.” 4 The AKS prohibits the following conduct: knowingly and willfully offer[ing] or pay[ing] any remuneration (including any kickback, bribe, or rebate) directly orindirectly, overtl y or covertly, in cash or in kind to any person to induce such person . . . to refer an individual to a person for the furnishing . . . of any item or service for which payment may be made in whole or in part unde r a Federal health care program. 42 U.S.C. § 1320a-7b(b)(2)(A). “This st atute criminalizes the payment of any funds or benefits designed to encourage an individual to refer another party to a Medicare provider for services to be paid for by the Medicare program.” United States v. Miles , 360 F.3d 472, 479 (5th Cir. 2004). Relator need only show that one purpose of the remunerati on was to induce such referrals. See United States v. Davis , 132 F.3d 1092, 1094 (5th Cir. 1998). There is no AKS

4 Relator’s other arguments are too speculativ e to create a fact issue as to Omnicare’s intent. Simmons v. Willcox , 911 F.2d 1077, 1082 (5th Cir. 1990) (“[S]peculative allegations . . . are insufficient to create a genuine issue of material fact precluding summary judgment.”). For example, Relator claims that Omnicare’s intent to induce referrals can be inferred from evidence of negotiations for p harmacy acquisitions occurring simultaneously with negotiations over provider agreements , and evidence of large accounts receivables occurring simultaneously with an SNF’s purchase of new facilities. But Relator provides no evidence linking these disparate activities and circumstances. Absent such evidence, Relator’s arguments amount to mere speculat ion and are therefore insufficient to create a genuine issue of material fact as to Omnicare’s intent. Case: 15-20629 Document: 00513738048 Page: 8 Date Filed: 10/28/2016No. 15-20629

9 violation, however, where the defendant merelyhopes or expects referrals from benefits that were designed wh olly for other purposes. E.g. , United States v. McClatchey , 217 F.3d 823, 834 (10th Cir. 200 0). Accordingly, the OIG-HHS explained in comments to th e AKS’s safe harbor provis ion that PPDs were not included among the safe harbors becaus e “by definition, [PPDs] are designed to induce prompt payment, and thus do not appear to violate the statute.” Medicare and State Heal th Care Programs: Fra ud and Abuse; OIG AntiKickback Provisions, 56 Fed. Reg. 35952, 35979 (July 29, 1991). Here, Relator’s ev idence regarding Omnicare’s treatment of SNFs’ Part A debt does not support a finding that Omnicare offered bene fits to SNFs that were designed to induce Medicare and Medicaid referrals. Relator’s evidence primarily shows Omnicare trying to colle ct verifiable debt and settle billing disputes without unnecess arily aggravating SNF c lients in the midst of ongoing or anticipated contract negotiat ions. At best, the evidence supports a finding that Omnicare did not want un resolved settlement negotiations to negatively impact its contract negotiatio ns with SNF clients and was, likewise, avoiding confrontational colle ction practices that might discourage SNFs from continuing to do bu siness with Omnicare. 5 None of the evidence, however,

5 For example, Omnicare’s email about an SNF named Shoreline shows that resolving billing disputes between Omnicare and Shore line was difficult, and failing to resolve the dispute “ha[d] the potential to derail [Omnicare’s] efforts to secure the [Shoreline] business.” Another email shows that Omnicare wanted to continue negotiating an acceptable payment plan for a delinquent Shoreline facility rather t han “immediately” cutting off services to that facility because of its relationship to the larger Shoreline business and the ongoing negotiations for a new provider agreement with Shoreline. Similarly, an email about an SNF named Five Star shows that Omnicare adjustedits collection practi ces for “extremely old balances” but continued normal collection practi ces for immediate balances because it did not want the “extremely old balances that are in disp ute” to become a “source of division.” In another instance, with an SNF named Harborside , Omnicare decided not to issue a demand letter on a delinquent account because it did no t want to “introduce an irritant that might impede progress on picking up [Harborside’s] ne wly acquired KY facilities.” Instead, it opted to wait another month before addressing th e issue with Harborside because Omnicare already had a meeting scheduled wi th Harborside that next month. Case: 15-20629 Document: 00513738048 Page: 9 Date Filed: 10/28/2016No. 15-20629

10 shows that Omnicare desi gned its settlement negotiat ions and debt collection practices to induce SNF clients to co ntinue making Medicare and Medicaid referrals to Omnicare. 6 Indeed, there is no evidence that the SNFs were told they were getting special benefits from Omnicare’s se ttlement negotiations and debt collection practices, le t alone that any such benefi ts were tied to Medicare and Medicaid referrals. 7 If the purporte d benefits were desi gned to encourage SNFs to refer Medicare and Medicaid patients to Omnicare, one might expect to find evidence showing that the SNFs at least kn ew about those benefits. Although Omnicare may have hoped fo r Medicare and Me dicaid referrals, absent any evidence that Omnicare designed its se ttlement negotiations and debt collection practices to induce such referrals, Relator cannot show an AKS violation. Similarly, the PPDs offered by Omni care did not violate the AKS because there is no evidence that they were de signed to induce re ferrals. Much of Relator’s evidence simp ly shows that PPDs were offered in contract

6 The closest question involves a two-year contract for monthly credit payments between Omnicare and Harborside. Relator argues that a March 2004 email shows that there was a billing dispute between Omnicare andHarborside, and that Omnicare wanted to resolve the dispute by offering monthly credits against Harborside’s future bills contingent upon a multi-year contract renewal. Omnicare and Harborside ultimately entered into a twoyear provider agreement, effective October 1, 2004, whereby Omnicare promised to pay Harborside $37,500 in monthly credits for a maxi mum of twenty-four months. Even if we were to assume arguendo that this evidence shows that Omnicare designed its promise of monthly credit payments to induce a multi-ye ar contract for future referrals, the alleged inducement occurred in 2004, which is outside the relevant time period for this litigation. Moreover, Relator points to no evidence showing how the agreement was carried out, if at all, during the relevant time period. Accordin gly, this evidence does not support an AKS violation during the relevant time period and thus cannot support her FCA claims in this litigation.

7 Relator also points to an email that says that settling billing disputes might give Omnicare the “‘goodwill’ necessary to receive se rious consideration for the Seacrest business.” This comment alone, without more, is not enough to show that Omnicare designedits negotiations to encourage Medicare and Medicaid referrals. It does not indicate, for example, that Omnicare planned to offer special benefits to produce this result, or that Seacrest believed Omnicare was offering special benefits. Case: 15-20629 Document: 00513738048 Page: 10 Date Filed: 10/28/2016No. 15-20629

11 negotiations and included in new contracts. But th ese documents fail to show that the PPDs were offered for the illegitimate purpos e of inducing referrals rather than the legitimate pu rpose of inducing payments. See Medicare and State Health Care Programs: Fraud and Abuse; OIG Anti-Kickback Provisions, 56 Fed. Reg. at 35979. Moreover, where PPDs were taken despite late payment, there was either additional co nsideration provided in the form of prompt payment of past-due accounts receivables or billing disputes that prevented SNFs from ma king prompt payments. Relator cannot survive summary judgment on this record. Relator also claims that Omnicare caused one SNF to submit factually false Part A cost reports because it di d not pay for the re ported costs within one year following the en d of the reporting period . As Relator’s expert explained, all reported co sts must be paid “within 1 ye ar after the end of the cost reporting period in which the liab ility is incurred.” Relator provided evidence that one of the SNFs filed a cost report reflecti ng $30,191 in drug expenses for the reporting period of November 1 to December 31, 2007, but paid nothing to Omnicare during that period. She argue s that a September 2008 Omnicare aging report showing that this SNF “owed $228,774.17 past due by 271+ days” proves that it never pa id the drug expenses within one year after the cost reporting period ended. Relator’s evidence does not support her argume nt. The SNF had until the end of 2008 to pay th e $30,191 in drug expenses because the reporting period for those expenses ended on December 31, 2007. But Relato r’s evidence only shows past-due account s receivable through September 2008. It does not address the remaining three months of the 2008 calend ar year, and thus does not show whether the SNF pa id the drug expense before the end of the year. Relator provides no additional evidence in support of this claim. We therefore agree with the district court that Re lator’s claim cannot survive summary Case: 15-20629 Document: 00513738048 Page: 11 Date Filed: 10/28/2016No. 15-20629

12 judgment because her eviden ce fails to support a fi nding that the drug costs were not paid within the legally authorized time period. Relator additionally ar gues that evidence showing pre-2006, past-due accounts receivables also supports her fa ctual falsity claim. This evidence, however, merely shows a settlement agreement rega rding allegations that Omnicare overcharged an SNF for pharmacyservices. It does not show that the SNF filed cost reports on the disputed overcharges. Even if it did, the evidence would still fail to support Relator’s factual falsity claim because it does not show that the SN F failed to file a workshee t A-8 adjustment after the one-year payment period ended. Accord ingly, this evidence also fails to support a finding that the cost reports were factually false. For the foregoing reasons, we affirm the district court’s dismissal of Relator’s FCA claims. C. Reverse FCA Claim The Reverse FCA imposes liability on “any person who . . . knowingly makes, uses, or causes to be made or used, a false record or statement to conceal, avoid, or decrease an obligation to pay or transmit money or property to the Government.” United States ex rel. Bain v. Ga. Gulf Corp ., 386 F.3d 648, 652–53 (5th Cir. 2004) (quoting 31 U.S.C. § 3729(a)(7)). “In a reverse false claims suit, the defendant’s action does not result in improper payment by the government to the defendant, but in stead results in no payment to the government when a payment is obligated.” Id. at 653. Under Omnicare’s 2006 CIA with th e OIG-HHS, Omnicare was required to disclose to the OIG-HHS in writ ing any “reportable events,” and then summarize such events in an annual report at the end of every reporting period. Reportable events include any “m atter that a reasonable person would consider a probable violation of crim inal, civil, or administrative laws applicable to any Federal health care program.” Case: 15-20629 Document: 00513738048 Page: 12 Date Filed: 10/28/2016No. 15-20629

13 Relator claims that her December 2007 email alleging that one of Omnicare’s customers was committi ng Medicare fraud constituted a “reportable event” under the CIA. Ac cordingly, the argument continues, Omnicare’s failure to disclo se this “reportable event” in its annual report to the OIG-HHS made the report a false record used to conceal an obligation to pay money to the government. The email Relator relies on relates to purp orted fraudulent Part A cost reports. Relator’s email, however, does not show a probable violation of federal health care laws. It says, in releva nt part, that customers with past-due accounts receivables will be committing Medicare frau d if Omnicare forgives their debt because “[t]hey have been reim bursed a[n]d they need to pay.” But cost reports use accrual-based accounting, which requires th e participant to report costs incurred duringthe reporting period, re gardless of when payment occurs. If costs are not liquidated within one year and the payment period is not extended under an exception, then an amended cost report should be filed through a worksheet A-8 adjustment. Thus, even assuming that the Part A debt was never paid, there is still no “pro bable violation” of the Part A health care program unless Relato r had information to beli eve that the customer in question would not be submitting a worksheet A-8 adjustment to reflect changes made to its reported Part A costs. The em ail does not indicate Relator had this information, and Relator provid es no evidence indicating otherwise. We therefore affirm the district court on the Reverse FCA claim. For the foregoing reasons, we AFFI RM the summary judgment, and we AFFIRM the denial of Rela tor’s discovery motions rais ed in Relator’s brief on appeal. Case: 15-20629 Document: 00513738048 Page: 13 Date Filed: 10/28/2016